Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-008858

10% owner sold 9,122 shares at $32.55 ($296,921)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Morningside Venture Investments Ltd 10% owner 2023-03-16 Sale −9,122 $32.55 $296,921 7,250,762 D
Open-market sales · 9,122 sh · avg $32.55 · $296,921
Loading xslF345X03/doc4.xml…